Format

Send to

Choose Destination
Medicine (Baltimore). 2016 Aug;95(31):e4349. doi: 10.1097/MD.0000000000004349.

Therapeutic role of hyperinsulinemia/euglycemia in aluminum phosphide poisoning.

Author information

1
aToxicological Research Center, Department of Clinical Toxicology, Loghman-Hakim Hospital, Shahid Beheshti University of Medical Sciences bExcellence Center of Clinical Toxicology, Iranian Ministry of Health, Tehran, Iran.

Abstract

BACKGROUND:

Different protocols have been suggested to treat aluminum phosphide (ALP) poisoning. We aimed to evaluate the possible therapeutic effect of hyperinsulinemia/euglycemia (HIE) in treatment of ALP poisoning.

METHODS:

In a prospective interventional study, a total of 88 ALP-poisoned patients were included and assigned into HIE group undergoing glucose/insulin/potassium (GIK) protocol and a control group that was managed by routine conventional treatments. The 2 groups were then compared regarding the signs and symptoms of toxicity and their progression, development of complications, and final outcome to detect the possible effect of GIK protocol on the patients' course of toxicity and outcome.

RESULTS:

The 2 groups were similar in terms of demographic characteristics and on-arrival vital signs and lab tests. Using GIK protocol resulted in significantly longer hospital stays (24 vs 60 hours; P < 0.001) and better outcomes (72.7% vs 50% mortality; P = 0.03). Regression analysis showed that GIK duration was an independent variable that could prognosticate mortality (odds ratio [95% confidence interval] = 1.045 [1.004,1.087]). The risk of mortality decreased by 4.5% each hour after initiation of GIK.

CONCLUSION:

GIK protocol improves the outcome of ALP poisoning and increases the length of hospital stay.

PMID:
27495040
PMCID:
PMC4979794
DOI:
10.1097/MD.0000000000004349
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center